In an analysis of 13,102 patients with cardiovascular disease, carriers with loss-of-function mutations in ANGPTL3 had an approximately 40% lower risk of cardiovascular disease than non-carriers (59). The gene discussed is ANGPTL3; the disease is cardiovascular disorder.